Firefly Neuroscience (AIFF) Stock Analysis

What Firefly Neuroscience does

Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

Key metrics

ETFs linked to AIFF

Broad-market and Technology sector ETFs an investor holding Firefly Neuroscience is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AIFF fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Firefly Neuroscience?

Firefly Neuroscience trades under the ticker AIFF on NASDAQ.

Which exchange is AIFF listed on?

AIFF is listed on NASDAQ.

What sector does Firefly Neuroscience operate in?

Firefly Neuroscience is classified in the Technology sector (Software - Application industry).

How can PortView help analyze AIFF in a portfolio?

PortView shows AIFF's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.